Immune monitoring to characterize T-cell responses of kidney transplant patients during co-stimulation blockade by belatacept
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2016
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics; Pharmacokinetics
- 19 Nov 2013 Planned end date changed from 6 Sep 2014 to 1 May 2015 as reported by Netherlands Trial Register.
- 19 Nov 2013 New source identified and integrated (Netherlands Trial Register; NTR4242).
- 15 May 2013 New trial record